Net loss in the fourth quarter of 2025 was $0.3 million or $0.05 per share compared to a net profit of $23,000 in the fourth ...

Good morning, everyone, and thank you for joining today's presentation of our 2025 full year results. I'm Nicola Frampton. I've been at Domino for almost 5 years, most recently as Chief Operations ...

CI&T Inc (NYSE:CINT) Q4 2025 Earnings Call Transcript March 11, 2026 CI&T Inc beats earnings expectations. Reported EPS is $0.1315, expectations were $0.09471. Narrator: Culture eats AI for breakfast.

The Beauty Health Company (NASDAQ:SKIN) Q4 2025 Earnings Call Transcript March 12, 2026 The Beauty Health Company misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were ...

The cost base reset, termed “fundamental,” is being supported by differentiated pricing terms that “reduce earnings variability, and support stronger long-term partnerships.” Chief Financial Officer ...

Cipher Pharmaceuticals Inc. ( CPH:CA) Q4 2025 Earnings Call March 13, 2026 8:30 AM EDT ...

Earnings call Bird Construction ended 2025 with a record CAD 11 billion backlog (up 45% YoY), stable revenue at CAD 3.4 billion, and improved adjusted EBITDA margin of 6.5%. Management guides to ...

ESS Tech, Inc. (NYSE:GWH) Q4 2025 Earnings Call Transcript March 5, 2026 ESS Tech, Inc. misses on earnings expectations. Reported EPS is $-1.97 EPS, expectations were $-0.76. Operator: Good afternoon, ...

A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising ...

The blood–brain barrier functions as an evolutionarily optimized vascular “filter,” permitting limited penetration of small molecules like temozolomide while effectively excluding most biologics from ...

Fierce Healthcare Senior Writer Anastassia Gliadkovskaya returned to the floor of the New York Stock Exchange Monday morning to shine a spotlight on ...

Earnings call CES posted all-time high Q4 revenue of CAD 664.5M (+10% YoY) and EBITDA of CAD 113.2M (+9% QoQ), with margins rebounding to 17%. Management raised the dividend by 29% and maintained a ...